|
|
|
|
Helicobacter pylori and its Role in the Pathogenesis of Diseases of the Digestive System
I.V. Kolosovych
- Bogomolets National Medical University, Kyiv, Ukraine
DOI: https://doi.org/10.15407/fz70.05.108
Abstract
Helicobacter pylori is a gram-negative bacterium that is quite common among the world’s population. To
date, the pathogenetic mechanisms of the bacterium’s influence on gastroduodenal ulcers and gastric cancer
have been most deeply studied. However, there is a growing number of sources devoted to the association of
Helicobacter pylori with the occurrence of many extra-gastric diseases. These data are quite contradictory
and controversial. Given the close anatomical and functional relationship of the digestive system (digestive
tract and digestive glands), it is quite natural that the bacterium Helicobacter pylori, which persists in the
antrum of the stomach, has a pathological effect on this system, causing the development of a number of
diseases and their complications. The purpose of this study is to analyze the current state of the problem
of the role of Helicobacter pylori in the pathogenesis of diseases of the digestive system. This review
presents the latest data on the pathogenetic mechanisms of gastroduodenal ulcer and gastric cancer. The
persistence of the bacterium in the pancreatic-biliary system causes cholecystitis, and gallstone disease,
including cholelithiasis, acute and chronic pancreatic inflammation, non-alcoholic fatty liver disease, and
liver cirrhosis. Various mechanisms of carcinogenesis of tumors of the liver, gallbladder and bile ducts,
and pancreas, in which Helicobacter pylori is directly involved, are highlighted. Further study of the role of
the bacterium as a predictor of the development of diseases of the digestive system and their complications
is promising and relevant
Keywords:
Helicobacter pylori, digestive system diseases, liver, gallbladder, pancreas, stomach
References
- FitzGerald R, Smith SM. An overview of helicobacter pylori infection. Method Mol Biol. 2021; 2283:1-14.
CrossRef
PubMed
- de Brito BB, da Silva FAF, Soares AS, Pereira VA, Santos MLC, Sampaio MM, Neves PHM, de Melo FF. Pathogenesis and clinical management of Helicobacter pylori gastric infection. World J Gastroenterol. 2019 Oct 7;25(37):5578-89.
CrossRef
PubMed PubMedCentral
- Sun Y, Zhang J. Helicobacter pylori recrudescence and its influencing factors. J Cell Mol Med. 2019 Dec;23(12):7919-25.
CrossRef
PubMed PubMedCentral
- Crowe SE. Helicobacter pylori infection. N Engl J Med. 2019 Mar 21;380(12):1158-65.
CrossRef
PubMed
- Ali A, AlHussaini KI. Helicobacter pylori: A contemporary perspective on pathogenesis, diagnosis and treatment strategies. Microorganisms. 2024 Jan 22;12(1):222.
CrossRef
PubMed PubMedCentral
- Šterbenc A, Jarc E, Poljak M, Homan M. Helicobacter pylori virulence genes. World J Gastroenterol. 2019 Sep 7;25(33):4870-84.
CrossRef
PubMed PubMedCentral
- Yamaoka Y. Helicobacter pylori virulence factors exploiting gastric colonization and its pathogenicity. Toxins (Basel). 2019 Nov 19;11(11):677.
CrossRef
PubMed PubMedCentral
- Oparin SO, Korotkyï VM, Kolosovych IV, Spitsyn RIu, Furmanenko MF, Kartashov BT, Martynovych LD, Krasovs'kyĭ VO, Butyrin SO, Zinchenko II, Rupitsev OO, Dzhurko MG. Operative treatment of complicated duodenal and pyloric ulcer disease. Klin Khir. 2000 Nov;(11):20-2. [Ukrainian].
- Wang M, Kong WJ, Zhang JZ, Lu JJ, Hui WJ, Liu WD, Kang XJ, Gao F. Association of Helicobacter pylori infection with colorectal polyps and malignancy in China. World J Gastrointest Oncol. 2020 May 15;12(5):582-91.
CrossRef
PubMed PubMedCentral
- Yang S, Xia YP, Luo XY, Chen SL, Li BW, Ye ZM, Chen SC, Mao L, Jin HJ, Li YN, Hu B. Exosomal CagA derived from Helicobacter pylori-infected gastric epithelial cells induces macrophage foam cell formation and promotes atherosclerosis. J Mol Cell Cardiol. 2019 Oct;135:40-51.
CrossRef
PubMed
- Gravina AG, Zagari RM, De Musis C, Romano L, Loguercio C, Romano M. Helicobacter pylori and extragastric diseases: A review. World J Gastroenterol. 2018 Aug 7;24(29):3204-21.
CrossRef
PubMed PubMedCentral
- Crowe SE. Helicobacter pylori Infection. N Engl J Med. 2019 Mar 21;380(12):1158-65.
CrossRef
PubMed
- Aydın EM, Demir TD, Seymen N, Said SS, Oktem-Okullu S, Tiftikci A, Cicek B, Tokat F, Tozun N, Ince U, Sezerman U, Sayi-Yazgan A. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer. Immunol Lett. 2021 Nov;239:1-11.
CrossRef
PubMed
- Chmiela M, Kupcinskas J. Review: Pathogenesis of helicobacter pylori infection. Helicobacter. 2019 Sep;24 Suppl 1:e12638.
CrossRef
PubMed PubMedCentral
- Helicobacter pylori infection. Nat Rev Dis Primers. 2023 Apr 20;9(1):20.
CrossRef
- Leja M, Grinberga-Derica I, Bilgilier C, Steininger C. Review: Epidemiology of Helicobacter pylori infection. Helicobacter. 2019 Sep;24 Suppl 1:e12635.
CrossRef
PubMed
- Malfertheiner P, Camargo MC, El-Omar E, Liou JM, Peek R, Schulz C, Smith SI, Suerbaum S. Helicobacter pylori infection. Nat Rev Dis Primers. 2023 Apr 20;9(1):19.
CrossRef
PubMed PubMedCentral
- Xie J, Liu D, Peng J, Wu S, Liu D, Xie Y. Iatrogenic factors of Helicobacter pylori eradication failure: lessons from the frontline. Expert Rev Anti Infect Ther. 2023 Apr;21(4):447-54.
CrossRef
PubMed
- Ansari S, Yamaoka Y. Helicobacter pylori virulence factors exploiting gastric colonization and its pathogenicity. Toxins (Basel). 2019 Nov 19;11(11):677.
CrossRef
PubMed PubMedCentral
- Sharndama HC, Mba IE. Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms. Braz J Microbiol. 2022 Mar;53(1):33-50.
CrossRef
PubMed PubMedCentral
- Mathews J, Malik P, Rai A, Lin J, Kim RS, Pan DH. A single centre experience of treatment outcomes for Helicobacter pylori infection among inner-city children and adolescents. Acta Paediatr. 2020 Sep;109(9):1860-6.
CrossRef
PubMed
- Cessa-Zanatta JC, García-Compeán D, MaldonadoGarza HJ, Borjas-Almaguer OD, Jiménez-Rodríguez AR, Del Cueto-Aguilera ÁN, González-González JA. Helicobacter pylori infection is associated with decreased odds for eosinophilic esophagitis in Mexican patients. Gastroenterol Hepatol. 2024 Feb;47(2):149-57. English, Spanish.
CrossRef
- Shah SC, Iyer PG, Moss SF. AGA clinical practice update on the management of refractory helicobacter pylori infection: Expert Rev Gastroenterol. 2021 Apr;160(5):1831-41.
CrossRef
PubMed PubMedCentral
- Abdelfattah T, Shahab O, Shah TU. Gastric intestinal metaplasia: when to treat? How to treat? Curr Opin Gastroenterol. 2021 Nov 1;37(6):602-8.
CrossRef
PubMed
- Kolosovych IV, Bezrodnyĭ BH, Chemodanov PV, Sysak OM. Surgical tactics at "difficult" perforative duodenal ulcers. Lik Sprava. 2013 Sep;(6):60-8. [Ukrainian].
CrossRef
- Zhang X, Arnold IC, Müller A. Mechanisms of persistence, innate immune activation and immunomodulation by the gastric pathogen Helicobacter pylori. Curr Opin Microbiol. 2020 Apr;54:1-10.
CrossRef
PubMed
- Baj J, Forma A, Sitarz M, Portincasa P, Garruti G, Krasowska D, Maciejewski R. Helicobacter pylori virulence factors-mechanisms of bacterial pathogenicity in the gastric microenvironment. Cells. 2020 Dec 25;10(1):27.
CrossRef
PubMed PubMedCentral
- Uberti AF, Callai-Silva N, Grahl MVC, Piovesan AR, Nachtigall EG, Furini CRG, Carlini CR. Helicobacter pylori urease: Potential contributions to Alzheimer's disease. Int J Mol Sci. 2022 Mar 13;23(6):3091.
CrossRef
PubMed PubMedCentral
- Korotkyĭ VM, Kolosovych IV. Pharmacotherapeutic aspects of early postoperative period in patients with complicated gastroduodenal ulcer. Klin Khir. 2002 Feb;(2):15-8. [Ukrainian].
- Yaratha K, Talemal L, Monahan BV, Yu D, Lu X, Poggio JL. Seasonal and Geographic Variation in Peptic Ulcer Disease and Associated Complications in the United States of America. J Res Health Sci. 2023 Dec 29;23(4):e00595.
CrossRef
PubMed PubMedCentral
- Javanbakhat P, Peeridogaheh H, Nemati R, Yazdanbod A, Teimourpour A, Sadeghnezhad M, Esmaelizad M, Teimourpour R. Exploring virulence factors of Helicobacter pylori isolated from gastric biopsy. Mol Biol Rep. 2024 Jan 25;51(1):192.
CrossRef
PubMed
- Haghighat S, Blandon C, Goldberg D, Kumar S. Association between country of birth and gastric intestinal metaplasia: a retrospective cohort study. Lancet Reg Health Am. 2023 Nov 28;28:100635.
CrossRef
PubMed PubMedCentral
- Li N, Xu X, Zhan Y, Fei X, Ouyang Y, Zheng P, Zhou Y, He C, Xie C, Hu Y, Hong J, Lu N, Ge Z, Zhu Y. YAP and β-catenin cooperate to drive H. pylori-induced gastric tumorigenesis. Gut Microbes. 2023 JanDec;15(1):2192501.
CrossRef
PubMed PubMedCentral
- Muzaheed. Helicobacter pylori oncogenicity: Mechanism, prevention, and risk factors. Sci World J. 2020 Jul 12;2020:3018326.
CrossRef
PubMed PubMedCentral
- Cheng M, Zheng Y, Fan Y, Yan P, Zhao W. The contribution of IL-17A-dependent low LCN2 levels to Helicobacter pylori infection: Insights from clinical and experimental studies. Int Immunopharmacol. 2023 Nov;124(Pt B):110960.
CrossRef
PubMed
- Choi IJ, Kim CG, Lee JY, Kim YI, Kook MC, Park B, Joo J. Family history of gastric cancer and Helicobacter pylori treatment. N Engl J Med. 2020 Jan 30;382(5):427-36.
CrossRef
PubMed
- Wang L, Wang H. The putative role of ferroptosis in gastric cancer: a review. Eur J Cancer Prev. 2023 Nov 1;32(6):575-83.
CrossRef
PubMed PubMedCentral
- Jeng KS, Chang CF, Sheen IS, Jeng CJ, Wang CH. Upper gastrointestinal cancer and liver cirrhosis. Cancers (Basel). 2022 May 2;14(9):2269.
CrossRef
PubMed PubMedCentral
- Santos MLC, de Brito BB, da Silva FAF, Sampaio MM, Marques HS, Oliveira E Silva N, de Magalhães Queiroz DM, de Melo FF. Helicobacter pylori infection: Beyond gastric manifestations. World J Gastroenterol. 2020 Jul 28;26(28):4076-93.
CrossRef
PubMed PubMedCentral
- Wang L, Chen J, Jiang W, Cen L, Pan J, Yu C, Li Y, Chen W, Chen C, Shen Z. The relationship between Helicobacter pylori infection of the gallbladder and chronic cholecystitis and cholelithiasis: A systematic review and meta-analysis. Can J Gastroenterol Hepatol. 2021 Jan 6;2021:8886085.
CrossRef
PubMed PubMedCentral
- Lim KPK, Lee AJL, Jiang X, Teng TZJ, Shelat VG. The link between Helicobacter pylori infection and gallbladder and biliary tract diseases: A review. Ann Hepatobiliary Pancreat Surg. 2023 Aug 31;27(3):241-50.
CrossRef
PubMed PubMedCentral
- Azimirad M, Sadeghi A, Hosseinkhan N, Mirbagheri SZ, Alebouyeh M. Microbiome analysis of bile samples in patients with choledocholithiasis and hepatobiliary disorders. Germs. 2023 Sep 30;13(3):238-53.
CrossRef
PubMed PubMedCentral
- Sulo P, Šipková B. DNA diagnostics for reliable and universal identification of Helicobacter pylori. World J Gastroenterol. 2021 Nov 7;27(41):7100-12.
CrossRef
PubMed PubMedCentral
- Osaki T, Lin Y, Sasahira N, Ueno M, Yonezawa H, Hojo F, Okuda M, Matsuyama M, Sasaki T, Kobayashi S, Tezuka S, Tanaka K, Dan N, Kuruma S, Egawa N, Kamiya S, Kikuchi S. Prevalence estimates of Helicobacter species infection in pancreatic and biliary tract cancers. Helicobacter. 2022 Feb;27(1):e12866.
CrossRef
PubMed PubMedCentral
- Cherif S, Rais H, Hakmaoui A, Sellami S, Elantri S, Amine A. Linking Helicobacter pylori with gallbladder and biliary tract cancer in Moroccan population using clinical and pathological profiles. Bioinformation. 2019 Oct 31;15(10):735-43.
CrossRef
PubMed PubMedCentral
- Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX. Biliary tract cancer. Lancet. 2021 Jan 30;397(10272):428-44.
CrossRef
PubMed
- Dangtakot R, Intuyod K, Chamgramol Y, Pairojkul C, Pinlaor S, Jantawong C, Pongking T, Haonon O, Ma N, Pinlaor P. CagA+ Helicobacter pylori infection and N-nitrosodimethylamine administration induce cholangiocarcinoma development in hamsters. Helicobacter. 2021 Aug;26(4):e12817.
CrossRef
PubMed
- Chai X, Wang J, Li H, Gao C, Li S, Wei C, Huang J, Tian Y, Yuan J, Lu J, Gao D, Zheng Y, Huang C, Zhou J, Shi G, Ke A, Liu F, Fan J, Cai J. Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma. Gut Microb. 2023 Jan-Dec;15(1):2156255.
CrossRef
PubMed PubMedCentral
- Fadieienko G. D., Gridnyev O. Y., Gridnieva S. V. Nonalcoholic fatty liver disease and Helicobacter pylori infection: is there a relationship? Modern Gastroenterol. 2024 Feb; 1(135): 60-5.
CrossRef
- Doulberis M, Srivastava S, Polyzos SA, Kountouras J, Papaefthymiou A, Klukowska-Rötzler J, Blank A, Exadaktylos AK, Srivastava DS. Active Helicobacter pylori infection is independently associated with nonalcoholic steatohepatitis in morbidly obese patients. J Clin Med. 2020 Mar 30;9(4):933.
CrossRef
PubMed PubMedCentral
- Feysa S.V. Lipid peroxidation and antioxidant defense status in patients with non-alcoholic fatty liver disease and concomitant hypothyroidism. Fiziol Zh. 2019;65(2):89-96.
CrossRef
- Wei L, Ding HG. Relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease: What should we expect from a meta-analysis? Medicine (Baltimore). 2021 Aug 6;100(31):e26706.
CrossRef
PubMed PubMedCentral
- Martin-Nuñez GM, Cornejo-Pareja I, Clemente-Postigo M, Tinahones FJ. Gut Microbiota: The missing link between helicobacter pylori infection and metabolic disorders? Front Endocrinol (Lausanne). 2021 Jun 17;12:639856.
CrossRef
PubMed PubMedCentral
- van Nieuwkerk CM, Kuipers EJ. Liver cirrhosis and peptic ulcer disease; a correlation with Helicobacter pylori? Neth J Med. 2000 Jun;56(6):203-5.
CrossRef
PubMed
- Koyanagi YN, Suzuki E, Imoto I, Kasugai Y, Oze I, Ugai T, Iwase M, Usui Y, Kawakatsu Y, Sawabe M, Hirayama Y, Tanaka T, Abe T, Ito S, Komori K, Hanai N, Tajika M, Shimizu Y, Niwa Y, Ito H, Matsuo K. Across-site differences in the mechanism of alcohol-induced digestive tract carcinogenesis: An evaluation by mediation analysis. Cancer Res. 2020 Apr 1;80(7):1601-10.
CrossRef
PubMed
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-49.
CrossRef
PubMed
- Nakane T, Fukunaga S, Nakano D, Tsutsumi T, Tanaka H, Chou T, Minami S, Ohuchi A, Nagata T, Takaki K, Takaki H, Miyajima I, Nouno R, Yoshinaga S, Mukasa M, Okabe Y, Kawaguchi T. Impact of metabolic dysfunction-associated fatty liver disease on the incidence of Helicobacter pylori-negative gastric cancer. Hepatol Res. 2023 Dec 29.
CrossRef
PubMed
- Salazar J, Le A. The heterogeneity of liver cancer metabolism. Adv Exp Med Biol. 2021;1311:127-36. .
CrossRef
PubMed PubMedCentral
- Youssefi M, Tafaghodi M, Farsiani H, Ghazvini K, Keikha M. Helicobacter pylori infection and autoimmune diseases; Is there an association with systemic lupus erythematosus, rheumatoid arthritis, autoimmune atrophy gastritis and autoimmune pancreatitis? A systematic review and meta-analysis study. J Microbiol Immunol Infect. 2021 Jun;54(3):359-69.
CrossRef
PubMed
Kolosovych IV, Hanol IV. Metabolic disorders caused by acute pancreatitis and ways of their correction using enteral nutrition of patients. Fiziol Zh. 2023; 69(4):92-
CrossRef
- [Ukrainian].
- Mederos MA, Reber HA, Girgis MD. Acute pancreatitis: A review. JAMA. 2021 Jan 26;325(4):382-90.
CrossRef
PubMed
- Kolosovych IV, Hanol IV. Purulent septic complications of acute pancreatitis and their pathogenetic relationship with Нelicobacter pylori. Novosti Khirurg. 2021 OctNov; (5): 542-8.
CrossRef
- Synelnyk TB, Kravchenko OO, Kostiuk OS, Savchuk OM, Sukhodolia SA, Ostapchenko LI. Distribution of serine proteases in blood plasma and pancreas in chronic pancreatitis and oncopathology. Fiziol Zh. 2022;68(6):31-43.
CrossRef
- Beyer G, Habtezion A, Werner J, Lerch MM, Mayerle J. Chronic pancreatitis. Lancet. 2020 Aug 15;396 (10249):499-512.
CrossRef
PubMed
- Gardner TB. Acute Pancreatitis. Ann Int Med. 2021 Feb;174(2):ITC17-ITC32.
CrossRef
PubMed
- Kunovsky L, Dite P, Jabandziev P, Dolina J, Vaculova J, Blaho M, Bojkova M, Dvorackova J, Uvirova M, Kala Z, Trna J. Helicobacter pylori infection and other bacteria in pancreatic cancer and autoimmune pancreatitis. World J Gastrointest Oncol. 2021 Aug 15;13(8):835-44.
CrossRef
PubMed PubMedCentral
- Hirabayashi M, Inoue M, Sawada N, Saito E, Abe SK, Hidaka A, Iwasaki M, Yamaji T, Shimazu T, Tsugane S. Author correction: Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A populationbased cohort study in a large Japanese population: the JPHC Study. Sci Rep. 2020 Jul 28;10(1):12950.
CrossRef
PubMed PubMedCentral
- Zhou BG, Mei YZ, Wang JS, Xia JL, Jiang X, Ju SY, Ding YB. Is Helicobacter pylori infection associated with pancreatic cancer? A systematic review and meta-analysis of observational studies. Ther Adv Chronic Dis. 2023 Feb 13;14:20406223231155119.
CrossRef
PubMed PubMedCentral
- Permuth JB, Rahman S, Chen DT, Waterboer T, Giuliano AR. A Case control study of the seroprevalence of Helicobacter pylori proteins and their Association with Pancreatic Cancer Risk. J Pancreat Cancer. 2021 Sep 16;7(1):57-64.
CrossRef
PubMed PubMedCentral
- Xu W, Zhou X, Yin M, Gao J, Weng Z, Xu C. The relationship between Helicobacter pylori and pancreatic cancer: a meta-analysis. Transl Cancer Res. 2022 Aug;11(8):2810-22.
CrossRef
PubMed PubMedCentral
- Kumar S, Metz DC, Kaplan DE, Goldberg DS. The association of Helicobacter pylori with pancreatic cancer. GastroHep. 2020 Jul;2(4):157-164.
CrossRef
PubMed PubMedCentral
- Gong Y, Chen S, Fu Y, Liu Y, Wang Y, Yang H, Liu H, Tang L. MUC4 is a novel mediator in H. pylori infection-related pancreatic cancer. Oncol Lett. 2021 Feb;21(2):123.
CrossRef
PubMed PubMedCentral
- Li P, Shu Y, Gu Y. The potential role of bacteria in pancreatic cancer: a systematic review. Carcinogenesis. 2020 Jun 17;41(4):397-404.
CrossRef
PubMed
- Panthangi V, Cyril Kurupp AR, Raju A, Luthra G, Shahbaz M, Almatooq H, Foucambert P, Esbrand FD, Zafar S, Khan S. Association between Helicobacter pylori infection and the risk of pancreatic cancer: A systematic review based on observational studies. Cureus. 2022 Aug 29;14(8):e28543.
CrossRef
- Chen Y, Wu G, Zhao Y. Gut microbiota and alimentary tract injury. Adv Exp Med Biol. 2020;1238:11-22.
CrossRef
PubMed
- Chen J, Ma J, Liu X, Duan S, Liang N, Yao S. The association between Helicobacter pylori infection with overweight/obesity: A protocol for a systematic review and meta-analysis of observational studies. Medicine (Baltimore). 2020 Jan;99(3):e18703.
CrossRef
PubMed PubMedCentral
|
|
|
|
|
|
|